A detailed history of Fmr LLC transactions in Shattuck Labs, Inc. stock. As of the latest transaction made, Fmr LLC holds 7,132,630 shares of STTK stock, worth $8.84 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,132,630
Previous 7,121,147 0.16%
Holding current value
$8.84 Million
Previous $63.7 Million 56.76%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$3.56 - $11.18 $40,879 - $128,379
11,483 Added 0.16%
7,132,630 $27.5 Million
Q1 2024

May 13, 2024

BUY
$7.37 - $10.09 $368,301 - $504,227
49,973 Added 0.71%
7,121,147 $63.7 Million
Q4 2023

Feb 13, 2024

BUY
$1.37 - $7.24 $1.01 Million - $5.34 Million
736,894 Added 11.63%
7,071,174 $50.4 Million
Q3 2023

Nov 13, 2023

SELL
$1.42 - $3.16 $51,706 - $115,065
-36,413 Reduced 0.57%
6,334,280 $9.63 Million
Q2 2023

Aug 11, 2023

BUY
$2.52 - $3.66 $8,391 - $12,187
3,330 Added 0.05%
6,370,693 $19.9 Million
Q1 2023

May 11, 2023

BUY
$2.5 - $4.72 $21,940 - $41,422
8,776 Added 0.14%
6,367,363 $18.7 Million
Q4 2022

Feb 13, 2023

BUY
$1.96 - $3.26 $2,520 - $4,192
1,286 Added 0.02%
6,358,587 $14.6 Million
Q3 2022

Nov 10, 2022

BUY
$2.6 - $5.52 $1,063 - $2,257
409 Added 0.01%
6,357,301 $17.2 Million
Q2 2022

Aug 12, 2022

BUY
$2.7 - $4.59 $6,372 - $10,832
2,360 Added 0.04%
6,356,892 $25.8 Million
Q1 2022

May 13, 2022

BUY
$4.22 - $8.89 $74,069 - $156,037
17,552 Added 0.28%
6,354,532 $27.1 Million
Q4 2021

Feb 14, 2022

BUY
$8.36 - $21.08 $155,195 - $391,329
18,564 Added 0.29%
6,336,980 $53.9 Million
Q3 2021

Nov 15, 2021

BUY
$17.57 - $28.95 $571,885 - $942,293
32,549 Added 0.52%
6,318,416 $129 Million
Q2 2021

Aug 13, 2021

BUY
$24.14 - $37.68 $152 Million - $237 Million
6,285,867 New
6,285,867 $182 Million

Others Institutions Holding STTK

About Shattuck Labs, Inc.


  • Ticker STTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,382,000
  • Market Cap $52.6M
  • Description
  • Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...
More about STTK
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.